Financials
- Market Capitalization 215.58 M
- Employee 95
- Founded N/A
- CEO Daniel Vitt
- Website www.imux.com
- Headquarter Delaware, United States
- FIGI BBG001M75SX4
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-4.34
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 3537 | NERV Minerva Neurosciences, Inc - Common Stock | 4.56 USD | -5.79% | -5.98% | +15.44% | +94.04% | 217.73 M USD | ||
| 3542 | TARA Protara Therapeutics, Inc. - Common Stock | 3.84 USD | +0.52% | -0.52% | -2.54% | +22.68% | 226.93 M USD | ||
| 3572 | KROS Keros Therapeutics, Inc. - common stock | 10.82 USD | -1.90% | -1.73% | +6.50% | -28.34% | 214.53 M USD | ||
| 3576 | GLSI Greenwich LifeSciences, Inc. - Common stock | 14.95 USD | -4.59% | -14.38% | +10.74% | +28.88% | 219.44 M USD |